tirzepatide medication class Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study Tirzepatide is a modern injectable
Description
Promising - I'm hopeful
Clinical studies have shown that patients using Wegovy lost an average of 14.9% to 17.4% of their initial body weight over 68 weeks, significantly more than what is typically achieved with diet and exercise alone
doi: 10.1111/acel.2016.15.issue-6 158 LardenoijeRVan Den HoveDLAVaessenTSJIatrouAMeuwissenKPVVan HagenBTJet al
But after a year on the medication, both reported feeling extremely ill, including vomiting multiple times a day and being unable to eat
